| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Vectus Biosystems Limited (AU: VBS)
VBS Technical Analysis
3
| As on 23rd Oct 2025 VBS STOCK Price closed @ 0.14 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.09 & Buy for SHORT-TERM with Stoploss of 0.14 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VBSSTOCK Price
| Open | 0.18 | Change | Price | % |
| High | 0.19 | 1 Day | 0.07 | 100.00 |
| Low | 0.12 | 1 Week | 0.07 | 100.00 |
| Close | 0.14 | 1 Month | 0.07 | 100.00 |
| Volume | 101557 | 1 Year | -0.11 | -44.00 |
| 52 Week High 0.28 | 52 Week Low 0.04 | ||||
AU Australia Most Active Stocks
| RML | 0.08 | % |
| THR | 0.02 | 100.00% |
| ARU | 0.46 | 9.52% |
| AXI | 0.02 | 0.00% |
| ADN | 0.02 | % |
| LMG | 0.04 | 33.33% |
| SGQ | 0.12 | 0.00% |
| ROG | 0.01 | % |
| VR1 | 0.05 | % |
| EUR | 0.26 | 4.00% |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
| VBS Daily Charts |
VBS Intraday Charts |
Whats New @ Bazaartrend |
VBS Free Analysis |
|
|
VBS Important Levels Intraday
| RESISTANCE | 0.27 |
| RESISTANCE | 0.23 |
| RESISTANCE | 0.20 |
| RESISTANCE | 0.18 |
| SUPPORT | 0.10 |
| SUPPORT | 0.08 |
| SUPPORT | 0.05 |
| SUPPORT | 0.01 |
VBS Forecast October 2025
| 4th UP Forecast | 0.24 |
| 3rd UP Forecast | 0.21 |
| 2nd UP Forecast | 0.19 |
| 1st UP Forecast | 0.17 |
| 1st DOWN Forecast | 0.11 |
| 2nd DOWN Forecast | 0.09 |
| 3rd DOWN Forecast | 0.07 |
| 4th DOWN Forecast | 0.04 |
VBS Weekly Forecast
| 4th UP Forecast | 0.14 |
| 3rd UP Forecast | 0.14 |
| 2nd UP Forecast | 0.14 |
| 1st UP Forecast | 0.14 |
| 1st DOWN Forecast | 0.14 |
| 2nd DOWN Forecast | 0.14 |
| 3rd DOWN Forecast | 0.14 |
| 4th DOWN Forecast | 0.14 |
VBS Forecast2025
| 4th UP Forecast | 0.54 |
| 3rd UP Forecast | 0.41 |
| 2nd UP Forecast | 0.33 |
| 1st UP Forecast | 0.25 |
| 1st DOWN Forecast | 0.03 |
| 2nd DOWN Forecast | -0.05 |
| 3rd DOWN Forecast | -0.13 |
| 4th DOWN Forecast | -0.26 |
Vectus Biosystems Limited ( AU Australia Symbol : VBS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
VBS Other Details
| Segment | EQ | |
| Market Capital | 56410784.00 | |
| Sector | Healthcare | |
| Industry | Biotechnology | |
| Offical website | > echo $website ; ?> | |
VBS Address
![]() |
||
VBS Latest News
VBS Business Profile
Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops treatment for fibrosis and high blood pressure. Its lead compound is VB0004, which has potent anti-hypertensive properties, as well as anti-fibrotic activity in the heart and kidneys. The company also intends to develop candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis and pulmonary fibrotic diseases. In addition, it develops AccuCal and RealCount software that improves speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories. The company was founded in 2005 and is based in Rosebery, Australia. Address: 3-11 Primrose Avenue, Rosebery, NSW, Australia, 2018
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

